Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Nicolas AidePauline FauchilleElodie CoquanGwenael FerronPierre CombeJérome MeunierJerôme AlexandreDominique BertonAlexandra LearyGaétan De RauglaudreNathalie BonichonEric Pujade LauraineFlorence JolyPublished in: European journal of nuclear medicine and molecular imaging (2020)
NCT01583322 ARCAGY/ GINECO GROUP GINECO-OV119, 24 April 2012.